2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine

C13H16N6O — CID 121351170

IUPAC2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine
SMILESCC1C(c2ncco2)=NC(N)=CN1Cc1nccn1C
InChIInChI=1S/C13H16N6O/c1-9-12(13-16-4-6-20-13)17-10(14)7-19(9)8-11-15-3-5-18(11)2/h3-7,9H,8,14H2,1-2H3
InChIKeyXWOYSUFZAZPDMP-UHFFFAOYSA-N
MW272.31 g/mol
LogP0.86
Rot. Bonds3

About 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine

2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine (PubChem CID 121351170) has the molecular formula C13H16N6O and a molecular weight of 272.31 g/mol. Its IUPAC name is 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine.

Molecular Properties

Compound Name2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine
PubChem CID121351170
Molecular FormulaC13H16N6O
Molecular Weight272.31 g/mol
Exact Mass272.14
IUPAC Name2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine
SMILESCC1C(c2ncco2)=NC(N)=CN1Cc1nccn1C
InChIInChI=1S/C13H16N6O/c1-9-12(13-16-4-6-20-13)17-10(14)7-19(9)8-11-15-3-5-18(11)2/h3-7,9H,8,14H2,1-2H3
InChIKeyXWOYSUFZAZPDMP-UHFFFAOYSA-N
XLogP0.86
TPSA85.47 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds3
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500272.31
LogP ≤ 50.86
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-[(1-cyclobutylimidazol-2-yl)methyl]-2-methyl-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine
CID 121351349
1-[(1,4-dimethylimidazol-2-yl)methyl]-2-methyl-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine
CID 121351478
2-methyl-1-[(5-methyl-1H-imidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine
CID 121351502
1,3-Dimethylimidazol-1-ium;2-(2,2-dimethylpropyl)-3-methyl-1,3-oxazol-3-ium;difluoride
CID 158206314
1,3-Dimethylimidazol-1-ium;2-(2,2-dimethylpropyl)-3-methyl-1,3-oxazol-3-ium;methane;difluoride
CID 158511941
1,2-Dimethylimidazole;2-methyl-1,3-oxazole
CID 159130346
1,2-Dimethylimidazole;2-methyl-4,5-dihydro-1,3-oxazole;2-methyl-1,3-oxazole
CID 159424034
Ethane;1-methylimidazole;2-methyl-1,3-oxazole
CID 164926605
2-(1-Imidazol-1-ylethyl)-1,3-oxazole
CID 174586320
(4S,5S)-1-ethyl-5-(1-ethylimidazol-2-yl)-4-[4-(1,3-oxazol-2-yl)piperidine-1-carbonyl]pyrrolidin-2-one
CID 138013070

Frequently Asked Questions

What is the IUPAC name of 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine?
The IUPAC name of 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine (CID 121351170) is 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine.
What is the SMILES notation for 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine?
The canonical SMILES for 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine is CC1C(c2ncco2)=NC(N)=CN1Cc1nccn1C.
What is the InChIKey of 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine?
The InChIKey is XWOYSUFZAZPDMP-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H16N6O/c1-9-12(13-16-4-6-20-13)17-10(14)7-19(9)8-11-15-3-5-18(11)2/h3-7,9H,8,14H2,1-2H3.
What are the key properties of 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine?
2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine has a molecular weight of 272.31 g/mol, XLogP of 0.86, 3 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-methyl-1-[(1-methylimidazol-2-yl)methyl]-3-(1,3-oxazol-2-yl)-2H-pyrazin-5-amine is sourced from PubChem (CID 121351170), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).